`
`
`
`LUN<.iR\ TRBUlVIPD·U EXECUTIVE. COMMITT£f.
`
`
`
`Action Hems from NY Meeting Oct 22nd, 2003
`
`
`
`Item
`
`Detuil
`
`Who
`
`When
`
`Write up draft of Phase I/Phase II
`
`(ADME/Tox) nnd send tto MR for oohs
`
`RR
`
`3011' Oct 2003
`
`2
`
`Contract for Euro ODD
`
`MR
`
`JO'h Oct 2003
`
`'.l
`
`
`
`S gm Drus Substonce 10 Giessen
`
`IR.R
`
`1511 Nov 2003
`
`4
`
`
`
`Sig,n ccnlmct with OptiNeb
`
`15" Nov 200:l
`CS/MR
`
`Pile fl a tent if possible for TRI UM PII
`
`s
`(Use Juanita)
`
`MR
`
`151' Dec 2003
`
`
`
`IRB/l!thics Protocol Submis.�ion
`WSILR/11O
`I 51� Dec 2003
`I 511 Dec 2003
`
`6
`
`7
`
`Reau mes ofpotcntiol J>rojcct Leaders to be
`
`
`
`
`
`
`collected for review
`
`MR
`
`8
`
`EMEA ODD filln�
`
`MR
`
`9
`
`
`
`
`
`S111.n inhnlo1ion toxicolo!i)' progrummc cs
`
`I S"' Dec 2003
`12111 Jan 2004
`
`10
`
`
`
`Propcsnls from CROs
`
`cs
`
`l21� Jon 2004
`
`WS/LR
`RricfPhasc II Centers (UCSIJIUM/Cfll
`
`151• Feb 2004
`II
`Vanrle1•b/hll'a1>11101•Ih/Gle,u·1:nlPt1r/.V/J1Jlogr,u
`flu11miv11r)
`
`12
`
`
`
`Pha� II centres meeting in New York
`
`MR
`
`7ll, Mar 2004
`
`13
`
`
`Prepare Phase II Protocol
`
`\VS/HO/LR
`15111 Mar2004
`
`14
`
`15
`
`Animal l'K and Repent Dose
`
`Remodelins Work
`
`(Urine metabolite.�)
`
`IND/CTX Ri:gulutory filings
`
`ws
`
`IS"' May 2004
`
`LungRx
`
`
`30'11 Jlun 2004
`
`S1ru1 Phase II Trial
`16
`
`LR/WSIHO
`30'h Sep 2004
`
`UNITED THERAPEUTICS, EX. 2102
`
`
`
`WATSON LAIBORATORIES v. UNITED THERAPEUTICS, IPR2017-01622
`
`Page 1 of 1
`
`IPR2021-00406
`United Therapeutics EX2073
`
`